# EDGAR Filing Document

**Accession Number:** 0001819253
**File Stem:** 0001193125-23-000272
**Filing Date:** 2023-1
**Character Count:** 2771
**Document Hash:** 7e9eb67838a95a27a2a817db6072e8ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-000272.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0001193125-23-000272

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** biote Corp.
- **CENTRAL INDEX KEY:** 0001819253
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 851791125
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038
- **BUSINESS PHONE:** 972-486-9346

**MAIL ADDRESS:**
- **STREET 1:** 1875 W. WALNUT HILL LN #100
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75038

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Haymaker Acquisition Corp. III
- **DATE OF NAME CHANGE:** 20200727

**BIOTE CORP.** 

1875 W. Walnut Hill Ln #100

Irving, TX 75038

---

| | |
|:---|:---|
| January 3, 2023 | **VIA EDGAR** |

---

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Jimmy McNamara

---

| | | | |
|:---|:---|:---|:---|
| **RE:** | **biote Corp.** | **biote Corp.** | **biote Corp.** |
|  | **Registration Statement on Form S-1 (File No. 333-268748)** | **Registration Statement on Form S-1 (File No. 333-268748)** | **Registration Statement on Form S-1 (File No. 333-268748)** |
|  | **Acceleration Request** | **Acceleration Request** | **Acceleration Request** |
|  |  | **Requested Date:** | **January 3, 2023** |
|  |  | **Requested Time:** | **4:30 P.M. Eastern Time** |

---

Dear Mr. McNamara,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, biote Corp. (the "***Registrant***") hereby requests that the U.S. Securities and Exchange Commission (the "***Commission***") accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the "***Registration Statement***") and declare the Registration Statement effective on January 3, 2023, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Ryan Sansom and Peter Byrne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Peter Byrne, counsel to the Registrant, at (212) 479-6778.

Very truly yours,

**biote Corp.** 

---

| |
|:---|
| /S/ Samar Kamdar |
| Samar Kamdar |
| Chief Financial Officer |

---

cc: Ryan Sansom, Cooley LLP

Peter Byrne, Cooley LLP